Two ways to guide artery puncture in people with peripheral arterial disease
Compares road mapping and ultrasound for guiding artery puncture in chronic limb-threatening ischemia.
Key facts
- Who runs it
- Sohag University
- Where
- Egypt1 site in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- Road Mapping Guided Puncture Versus Ultrasound Guided Puncture During Retrograde Angioplasty Feasibility and Safety
- Status
- Recruiting
- People taking part
- 32 people, planned
- Started
- 1 Feb 2026
- Expected to end
- 1 Mar 2027
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Road-map guided versus US guided retrograde access
- Record updated
- 23 February 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with critical limb-threatening ischemia (very poor blood flow to the leg) who need a needle puncture into the artery from below. It compares two ways of guiding that puncture: X-ray road mapping and ultrasound.
- Age
- 18 Years and older
- Sex
- All
- Disease stage
- Critical limb-threatening ischemia (CLTI) with significant blockages in the femoropopliteal artery (thigh and knee artery). Rutherford Class 5: wounds or ulcers that do not heal.
- Earlier treatment
- Access to the artery from above (antegrade) failed or was not possible. People must be planned for a procedure inside the artery, such as angioplasty or a stent, through access from below (retrograde).
Main reasons for not taking part
- Active infection where the needle goes in, especially over the ankle
- Severe hardening (calcium build-up) of the arteries that makes the puncture unsafe
- Major changes in the shape of the arteries that make the puncture unsafe
The registry criteria, word for word
Show all 6 criteriaShow less
Who can take part
- Adults : Both male and female participants
- Diagnosed with critical limp threatening ischemia (CLTI):; significant occlusions in the femoropopliteal; o Rutherford Class 5: Non-healing wounds or ulcers
- Failed or unable to achieve antegrade access:; Patients requiring retrograde puncture for the procedure
- Planned intervention with retrograde access: Candidates for endovascular interventions, including angioplasty, stent deployment
Who cannot take part
- Active infection at the puncture site: Any localized infection, particularly over the ankle region , will be an exclusion
- Severe calcification or anatomical abnormalities: Patients with excessive arterial calcification or significant anatomical distortion preventing safe retrograde puncture
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The study aims to compare the technical feasibility and safety of road mapping-guided versus ultrasound-guided retrograde arterial puncture in patients with (CLTI) as measured by:
Read full original descriptionShow less
* Puncture success rate * Access-related complication rate (e.g., hematoma, vessel dissection, perforation)
The 2 groups in the trial
- Road Mapping Guided PunctureTreatment being tested
Treatment: Road-map guided versus US guided retrograde access
- Ultrasound Guided PunctureExisting treatment, for comparison
Treatment: Road-map guided versus US guided retrograde access
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Road Mapping Guided Puncture Versus Ultrasound Guided Puncture During Retrograde Angioplasty Feasibility and Safety
- Plain-language title
- Two ways to guide artery puncture in people with peripheral arterial diseaseGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Record updated
- 23 February 2026